Orthofix (OFIX) Releases New Data for Spinal Fusion Procedures
https://www.zacks.com/stock/news/2202514/orthofix-ofix-releases-new-data-for-spinal-fusion-procedures?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2202514
Dec 27, 2023 - According to Orthofix (OFIX), this data highlights the noninvasive and cost-effective nature of SpinalStim, enabling patients to continue their healing in the comfort of their homes.
0
Here's Why You Should Retain QIAGEN (QGEN) Stock for Now
https://www.zacks.com/stock/news/2203003/here-s-why-you-should-retain-qiagen-qgen-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2203003
Dec 28, 2023 - Investors remain optimistic about QIAGEN (QGEN), backed by strategic alliances and potential in the Molecular Diagnostics arena.
0
Reasons to Buy Prestige Consumer (PBH) Stock for Now
https://www.zacks.com/stock/news/2203002/reasons-to-buy-prestige-consumer-pbh-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2203002
Dec 28, 2023 - Investors remain optimistic about Prestige Consumer (PBH), backed by the robust strength of its consumer brands portfolio.
0
Here's Why Investors Should Retain Labcorp (LH) Stock for Now
https://www.zacks.com/stock/news/2203637/here-s-why-investors-should-retain-labcorp-lh-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2203637
Dec 29, 2023 - Investors remain optimistic about Labcorp (LH) due to impressive partnerships and expansion efforts in targeted high-growth areas.
0
Globus Medical (GMED) Gains From Innovation Amid Macro Issues
https://www.zacks.com/stock/news/2203657/globus-medical-gmed-gains-from-innovation-amid-macro-issues?cid=CS-ZC-FT-analyst_blog|zer_report_update-2203657
Dec 29, 2023 - Globus Medical (GMED) is particularly seeing notable gains in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.
0
Why DexCom (DXCM) Could Beat Earnings Estimates Again
https://www.zacks.com/stock/news/2211643/why-dexcom-dxcm-could-beat-earnings-estimates-again?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2211643
Jan 17, 2024 - DexCom (DXCM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
0
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now
https://www.zacks.com/stock/news/2212771/reasons-to-retain-dexcom-dxcm-stock-in-your-portfolio-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2212771
Jan 19, 2024 - DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
0
Intuitive Surgical (ISRG) Seeks FDA Nod for Next-Gen da Vinci 5
https://www.zacks.com/stock/news/2216520/intuitive-surgical-isrg-seeks-fda-nod-for-next-gen-da-vinci-5?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2216520
Jan 26, 2024 - Intuitive Surgical (ISRG) aims to boost its da Vinci portfolio with the addition of its next-generation da Vinci 5 multiport surgical robot.
0
DaVita (DVA) Expands Operational Footprint Via New Agreement
https://www.zacks.com/stock/news/2236716/davita-dva-expands-operational-footprint-via-new-agreement?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2236716
Mar 06, 2024 - DaVita's (DVA) latest agreement is expected to serve a wider patient pool across Latin America.
0
Buy 5 Medical Devices Stocks for a Stable Portfolio in 2024
https://www.zacks.com/stock/news/2240686/buy-5-medical-devices-stocks-for-a-stable-portfolio-in-2024?cid=CS-ZC-FT-analyst_blog|investment_ideas-2240686
Mar 14, 2024 - We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These are: AORT, TMDX, DXCM, SWAV, EW.
0